Back to top
more

Shockwave Medical Inc. (SWAV)

(Delayed Data from NSDQ)

$43.43 USD

43.43
437,633

+2.29 (5.57%)

Updated May 3, 2019 04:00 PM ET

After-Market: $43.32 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

3 Reasons to Retain Ecolab (ECL) Stock in Your Portfolio

Investors continue to be optimistic about Ecolab (ECL) owing to its strong business.

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.

3 Reasons to Add Inogen (INGN) Stock to Your Portfolio Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Nevro (NVRO) Gains Following FDA Approval for Senza HFX iQ

Nevro (NVRO) gets FDA approval for its next-generation SCS system, Senza HFX iQ, for treating chronic back and leg pain.

Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Accuray's (ARAY) New Treatment Package to Boost Patient Outcome

Accuray's (ARAY) latest automated breast cancer treatment package for the Radixact System is expected to extend and improve the quality of patients' lives.

Shockwave Medical (SWAV) Gains But Lags Market: What You Should Know

Shockwave Medical (SWAV) closed at $274.67 in the latest trading session, marking a +1.84% move from the prior day.

Humana (HUM) Brings Affordable MA Plan to U.S. Veterans

Humana (HUM) ties up with USAA Life to develop a Medicare Advantage plan that transcends the VA system to fetch added healthcare benefits for veterans.

QuidelOrtho (QDEL) Reports Solid Preliminary Q3 Revenues

QuidelOrtho's (QDEL) revenue growth in the third quarter is likely to have been boosted by continued strength in its non-COVID-19 product sales.

Thermo Fisher (TMO) Launches New TaqPath Panel in Europe

This panel of Thermo Fisher (TMO), apart from detecting GI bacteria, also helps in identifying the root cause of an infection and administering the best suitable treatment fast.

Shockwave Medical (SWAV) Gains As Market Dips: What You Should Know

In the latest trading session, Shockwave Medical (SWAV) closed at $267.96, marking a +1.5% move from the previous day.

3 Reasons to Retain Allscripts (MDRX) Stock in Your Portfolio

Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.

Edwards Lifesciences (EW) TAVR Sales Strong Amid Macro Issues

Edwards Lifesciences (EW) expects full-year 2022 underlying sales growth in the mid-single-digit range on the back of strength in demand for products used in more intense surgeries.

Neogen (NEOG) Q1 Earnings Top Estimates, Operating Margin Dips

Neogen's (NEOG) allergen and environmental sanitation product lines decline due to reduced buying patterns from customers and supply chain disruptions of certain products.

Nalak Das headshot

Top 5 Large-Cap Stocks Flying High YTD in Terrible 2022

We have narrowed our search to five large-cap stocks that have popped more than 20% year to date. These are: DINO, ENPH, LPLA, SWAV and TRGP.

Here's Why You Should Retain Chemed (CHE) Stock for Now

Investors are optimistic about Chemed's (CHE) Roto-Rooter business, which is witnessing continued demand for plumbing, drain cleaning services and water restoration services.

    SmileDirectClub (SDC) Hurt by Lower Spending, Margin Woe

    The ongoing macroeconomic challenges continue to impact SmileDirectClub's (SDC) core demographic and business spending.

      Intuitive Surgical (ISRG) Up After da Vinci SP's Japan Approval

      Intuitive Surgical (ISRG) gains approval in Japan for its single-port robotic surgical system, da Vinci SP. It will enable surgeons to provide minimally invasive experience for complex procedures.

      Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?

      Smart Beta ETF report for XHE

      Shockwave Medical (SWAV) Gains But Lags Market: What You Should Know

      In the latest trading session, Shockwave Medical (SWAV) closed at $278.96, marking a +0.32% move from the previous day.

      Haemonetics (HAE) Hospital Arm Aids, Macro Issues Persist

      Robust performance of Haemonetics' (HAE) Hospital business, on continued strength in the Hemostasis Management product line, instills optimism.

        3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

        Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.

          Veeva Systems' (VEEV) Latest Launches to Enhance Workflow

          Veeva Systems' (VEEV) new offerings are expected to aid the marketing and field teams with more accurate and actionable insights into patient and HCP touchpoints.